Head of Marketing, Noven Pharmaceuticals
Kristen Sharron-Albright, the current Head of Marketing at Noven Pharmaceuticals, was until
recently VP Sales and Marketing, Anti-Infective Marketing and Institutional Sales Specialty Care
Business Unit at Pfizer. She is an experienced business leader with 20 years of experience in the
pharmaceutical and biotechnology industries. She has a strong track record of delivering results
in highly competitive and complex markets. Starting her career in sales at Eli Lilly, she then held
positions of increasing responsibility at Lilly, Neurogen, and Pfizer, where she was responsible for
sales and marketing in a franchise business model. In her spare time she volunteers, serves on the
leadership committee for her church, and enjoys hiking.
Vice President New Products, Alexion Pharmaceuticals, Inc.
Nick Gurreri is a business leader and General Manager with over 25 years of consistently achievin-ghigh performance and profitability through strong leadership and cohesive team building in the
biopharmaceutical and medical device industries. Nick has held executive positions at Medgenics,
Insmed, Pfizer, Pharmacia and Bristol-Myers Squibb. Nick received a BS in Mechanical Engineering-from the University of Delaware, and also acquired a Master of Science in Information Assurance at
Carnegie Mellon University.
Commercial Professional, Skysis LLC
Lewis Chapman has spent over thirty years in health care management. He served as VP of
Global Strategic Marketing at BioMarin Pharmaceutical from 2007 to 2012, where he was
responsible for strategic marketing and product portfolio analyses, and implemented medical
education, brand enhancement and sales support programs on a worldwide basis. He oversaw
the global launch of Kuvan, which in the U.S. was 112% to budget in 2008, the first year on the
market. Previously he with Alpha Innotech Corporation as Vice President Global Sales and
Marketing, where global sales grew 26% in 2004 and 22% in 2005 under his leadership. Lewis
started his career with Eli Lilly & Company, with roles at Syntex and Genentech, where he was
responsible for the global commercial launch of Activase (t-PA), the largest biopharm product
launch in the history of the industry up to that time (first year sales $187 million).
Sebastian “Sebby” borriello
Vice President, Market Development Cempra Inc.
Sebby is currently serving as the Vice President, Market Development at Cempra Pharmaceutical.
Sebby’s career has included executive sales and marketing positions at Mentor Worldwide LLC,
Johnson & Johnson Healthcare Systems Inc., Ethicon, Inc. and Ortho-McNeil Pharmaceuticals,
Inc. Sebby received his B.A. in Public Administration from St. John’s University in ‘81, and
received his M.S. in Organizational Dynamics from the University of Pennsylvania in 2001.